| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 1e-08 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.25 | 9e-06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |